These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33401889)

  • 1. Hydroxychloroquine, TTP, COVID-19, and SLE.
    Sookaromdee P; Wiwanitkit V
    Turk J Haematol; 2021 Feb; 38(1):99-100. PubMed ID: 33401889
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
    Mendel A; Bernatsky S; Askanase A; Bae SC; Clarke AE; Costedoat-Chalumeau N; Gladman DD; Gordon C; Hanly J; Jacobsen S; Kalunian K; Mak A; Mosca M; Pons-Estel BA; Ruiz-Irastorza G; Urowitz M; Vinet É
    Ann Rheum Dis; 2021 Feb; 80(2):1-2. PubMed ID: 32586918
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?
    Mir TH
    Turk J Haematol; 2021 Jun; 38(2):155-157. PubMed ID: 33543863
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
    Yue C; Su J; Fan X; Song L; Jiang W; Xia J; Shi T; Zhang X; Li X
    Orphanet J Rare Dis; 2020 Aug; 15(1):225. PubMed ID: 32859237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
    Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
    Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.
    Mar N; Mendoza Ladd A
    J Thromb Thrombolysis; 2011 Jan; 31(1):119-21. PubMed ID: 20814810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study.
    Merayo-Chalico J; Demichelis-Gómez R; Rajme-López S; Aparicio-Vera L; Barrera-Vargas A; Alcocer-Varela J; Gómez-Martín D
    Thromb Res; 2014 Nov; 134(5):1020-7. PubMed ID: 25257921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review.
    Liang SJ; Zheng QY; Li MS; Lv MY; Chen WT; Yang Y
    Clin Rheumatol; 2022 Aug; 41(8):2561-2569. PubMed ID: 35524885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus.
    Musio F; Bohen EM; Yuan CM; Welch PG
    Semin Arthritis Rheum; 1998 Aug; 28(1):1-19. PubMed ID: 9726331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.
    Teh CL; Cheong YK; Wan Musa WR; Wan Mohd Akbar SA; Mat Husin N; Gun SC
    Ann Rheum Dis; 2021 May; 80(5):e69. PubMed ID: 32737111
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
    Jakhar D; Kaur I
    Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
    [No Abstract]   [Full Text] [Related]  

  • 13. Upfront rituximab therapy for thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case-based review.
    Mutoh T; Ohashi K; Nagai T; Sugiura A; Kudo M; Fujii H
    Rheumatol Int; 2023 Feb; 43(2):373-381. PubMed ID: 35962219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases.
    Li J; Jiang JJ; Wang CY; Jian S; Zhou Y; Ma MS; Tang XY; Wang L; Quan MY; Zhang Y; Xiao J; He YY; Song HM
    Ital J Pediatr; 2019 Apr; 45(1):55. PubMed ID: 31036039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients.
    Huang H; Sun W; Liang Y; Long XD; Peng Y; Liu Z; Wen X; Jia M
    Ren Fail; 2014 Sep; 36(8):1263-7. PubMed ID: 24990576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e70. PubMed ID: 32737109
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report.
    Kafle P; Malakoff GL
    Tenn Med; 2012 May; 105(5):37-8. PubMed ID: 22611780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus presenting as thrombotic thrombocytopenic purpura.
    Jonsson OG; Fink CW
    J Rheumatol; 1990 Jul; 17(7):973-4. PubMed ID: 2213766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs.
    Vasoo S; Thumboo J; Fong KY
    Lupus; 2002; 11(7):443-50. PubMed ID: 12195786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.